×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Leukemia

Gary Stromberg
Helping others is the last phase of recovery.
Kristie L. Kahl
Time-limited treatment could be the new wave of research in the treatment of chronic lymphocytic leukemia (CLL), according to Nicole Lamanna, M.D.
Jessica Skarzynski
Here are the top 5 CURE stories for February 2019.
Beth Fand Incollingo
 Brian Boyle, who plays center for the New Jersey Devils, has announced that his blood cancer is in remission.

 
Kristie L. Kahl
The Food and Drug Administration granted a priority review to Tibsovo (ivosidenib) for the treatment of patients with newly diagnosed acute myeloid leukemia (AML) with an IDH1 mutation who are not eligible for standard therapy.
Understanding CLL as a chronic disease.
Knowing treatment options and the possibilities of supportive care.
Utilizing clinical trials and understanding potential side effects and complications.
Finding follow-up care and emotional support.
Serving as a caregiver for a loved one going through a CLL diagnosis and treatment while utilizing resources to take care of oneself.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

Patient Caregiver Advocate Other